Purchase Order 36C26122P0997

Research Triangle Institute (RTI International) received a $541,000 firm fixed-price delivery order from the Agency for Healthcare Research and Quality (AHRQ) to conduct research on improving the management of menopausal symptoms. The award, issued on July 17, 2024, with an ultimate completion date of May 4, 2026, represents a no-cost extension and carries no set-aside designation. The work will be performed at RTI's headquarters in Research Triangle Park, North Carolina. This delivery order...

The National Institute of Child Health and Human Development (NICHD) awarded a $2.19 million delivery order to Health Decisions, Inc., a clinical research organization based in Morrisville, North Carolina, on September 1, 2023. This contract, designated as Task Order 5 under the Ovaprene program, supports finalization activities, procurement of regulatory approval, and complete start-up coordination for the Ovaprene vaginal device clinical trial. The work is structured as a cost-plus-fixed-fee...

The National Institute of Child Health and Human Development (NICHD) awarded a delivery order valued at $2.08M to SRI International for preclinical research and development activities focused on pharmacokinetics/pharmacodynamics (PK/PD) studies and metabolic profiling of contraceptive agents. This non-severable contract, issued on April 13, 2023, with an ultimate completion date of December 12, 2025, will be performed at SRI International's Menlo Park, California facility under a...

The National Institute of Child Health and Human Development issued a delivery order to SRI International on September 27, 2010, with a ceiling value of $852,628.88 for clinical supplies and stability testing of DMAU capsules under a cost-plus-fixed-fee pricing structure. Place of performance is Menlo Park, CA. The order is for DMAU clinical supplies and stability testing work and carries an ultimate completion date of September 28, 2014. No set-aside applied to this delivery order.

The National Institute of Child Health and Human Development (NICHD) awarded a delivery order valued at $2.36 million to Health Decisions, Inc. on August 1, 2025, to serve as the Statistical and Clinical Coordinating Center for the Phase IIB clinical trial of subcutaneous levonorgestrel butanoate, a female contraceptive method under development. The contract, structured as a cost-plus-fixed-fee arrangement, is set aside for small businesses and extends through December 31, 2028. Health...

The National Institute of Child Health and Human Development issued a delivery order to Sri International on September 5, 2019, with a ceiling value of $1,115,231.02 for research and development of preclinical contraceptives under the Biological Testing Facility task order vehicle. Place of performance is Menlo Park, CA. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of September 27, 2020. The work encompasses preclinical contraceptive research and...

The National Institute of Child Health and Human Development issued a delivery order to Sri International on September 24, 2012, with a ceiling value of $2,065,309.63 under a Cost Plus Fixed Fee pricing structure for biological testing facility services including clinical supplies and stability testing of levonorgestrel butanoate (LNG-B). Place of performance is Menlo Park, CA. The order has an ultimate completion date of September 28, 2017. No set-aside was used for this procurement.

The U.S. Department of Veterans Affairs (VA) Technology Acquisition Center awarded a $921,640.00 firm fixed-price contract to Helpsort Psychology PC, a woman-owned small business, for mobile application testing and content writing services to support the VA's National Center for Post-Traumatic Stress Disorder (PTSD) Mental Health Mobile Applications. The contract, which does not have a set-aside designation, includes a base period and four one-year option periods, with work to be performed...

The National Institute of Child Health and Human Development (NICHD) awarded a delivery order valued at $1.09 million to the University of California, Davis to support the Contraceptive Clinical Trials Network—Female Sites initiative. This Cost No Fee contract, awarded on September 25, 2018 with completion targeted for July 14, 2026, funds applied research and exploratory development activities to evaluate the pharmacokinetics, pharmacodynamics, cycle control, and safety of levonorgestrel...

The Food and Drug Administration (FDA) awarded a firm fixed-price contract valued at $811,680.97 to Research Triangle Institute (RTI International) on September 28, 2023, for services supporting a research study on incorporating women's experiences and prioritization of treatment outcomes into regulatory decision-making for medical devices addressing women's health conditions, specifically genitourinary syndrome of menopause. The contract, which extends through September 30, 2026, originated...